| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |